P471 Efficacy and safety of switching from reference infliximab to biosimilar infliximab in patients with inflammatory bowel disease: first French experience
Soret, P.-A., Prieux-Klotz, C., Avouac, J., Molto, A., Dior, M., Brieau, B., Dreanic, J., Camus, M., Barret, M., Coriat, R., Conort, O., Chast, F., Goulvestre, C., Le Jeunne, C., Dougados, M., Nahon,Volume:
11
Langue:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx002.596
Date:
February, 2017
Fichier:
PDF, 80 KB
english, 2017
File converter
Plus de résultats de recherche
More benefits 
